dsp 4 has been researched along with 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blier, P; Cassano, T; Cuomo, V; Gobbi, G; Hen, R; Morgese, MG; Radja, F; Santarelli, L | 1 |
1 other study(ies) available for dsp 4 and 7,7-diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one
Article | Year |
---|---|
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function.
Topics: Action Potentials; Analgesics; Animals; Benzylamines; Drug Interactions; Indoles; Isoindoles; Locus Coeruleus; Male; Mice; Mice, Knockout; Neurokinin-1 Receptor Antagonists; Neurons; Neurotoxins; Norepinephrine; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Receptors, Neurokinin-1; Serotonin | 2007 |